Literature DB >> 21490618

CD70 is selectively expressed on Th1 but not on Th2 cells and is required for Th1-type immune responses.

Tatsuyoshi Kawamura1, Youichi Ogawa, Osamu Shimozato, Takashi Ando, Atsuhito Nakao, Tetsuji Kobata, Ko Okumura, Hideo Yagita, Shinji Shimada.   

Abstract

The interaction between CD27 and CD70 provides a costimulatory signal for T-cell survival. Although the role of CD27 signaling in CD8(+) T cells has been well defined, its role in CD4(+) T cells is relatively unknown. Here, we report that CD70 is specifically expressed on differentiated T-helper (Th)1 cells, but not on Th2 cells. Upon activation, CD70 expression increased markedly on Th1 cells, but remained undetectable on Th2 cells. We demonstrate that CD27 is involved in naive T-cell expansion in Th1-type, but not in Th2-type, immune responses as in vivo treatment with anti-CD70 monoclonal antibody at induction resulted in a significant reduction of delayed-type and contact hypersensitivity responses, but not asthmatic responses. In both Th1-type responses, during the priming phase, CD70 was detected at earlier time points on dendritic cells (DCs) and at later time points on CD4(+) T cells. Our results indicate that CD70 may be useful as a marker to distinguish Th1 from Th2 cells. More importantly, CD27 function may be controlled by the differentially regulated kinetics of CD70 expression on DCs and CD4(+) T cells, and Th1 cell-specific CD70 expression may be involved in an amplification loop for polarized Th1-type immune responses through T cell-T cell interactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490618     DOI: 10.1038/jid.2011.36

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

Review 1.  TNF superfamily in inflammatory disease: translating basic insights.

Authors:  Michael Croft; Wei Duan; Heonsik Choi; So-Young Eun; Shravan Madireddi; Amit Mehta
Journal:  Trends Immunol       Date:  2011-12-13       Impact factor: 16.687

2.  CD70 and Th17 are involved in human contact sensitivity.

Authors:  David S Lee; Nicholas Gulati; Frank Martiniuk; William R Levis
Journal:  J Drugs Dermatol       Date:  2011-10       Impact factor: 2.114

3.  Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's disease.

Authors:  Neil E McCarthy; Charlotte R Hedin; Theodore J Sanders; Protima Amon; Inva Hoti; Ibrahim Ayada; Vidya Baji; Edward M Giles; Martha Wildemann; Zora Bashir; Kevin Whelan; Ian Sanderson; James O Lindsay; Andrew J Stagg
Journal:  J Clin Invest       Date:  2015-07-13       Impact factor: 14.808

4.  Spermatogonia apoptosis induction as a possible mechanism of Toxoplasma gondii-induced male infertility.

Authors:  Jasem Saki; Mohamad Sabaghan; Reza Arjmand; Ali Teimoori; Mohammad Rashno; Ghasem Saki; Saeedeh Shojaee
Journal:  Iran J Basic Med Sci       Date:  2020-09       Impact factor: 2.699

5.  CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy.

Authors:  Anna Wasiuk; James Testa; Jeff Weidlick; Crystal Sisson; Laura Vitale; Jenifer Widger; Andrea Crocker; Lawrence J Thomas; Joel Goldstein; Henry C Marsh; Tibor Keler; Li-Zhen He
Journal:  J Immunol       Date:  2017-11-06       Impact factor: 5.422

6.  Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cells.

Authors:  Lucy W Barrett; Vanessa S Fear; Bree Foley; Katherine Audsley; Samantha Barnes; Hannah Newnes; Alison McDonnell; Fiona M Wood; Mark W Fear; Jason Waithman
Journal:  Burns Trauma       Date:  2022-04-29

7.  Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors.

Authors:  Chuan Jin; Di Yu; Victoria Hillerdal; AnnaCarin Wallgren; Alex Karlsson-Parra; Magnus Essand
Journal:  Mol Ther Methods Clin Dev       Date:  2014-03-05       Impact factor: 6.698

8.  Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells.

Authors:  Alexei F Kirkin; Karine N Dzhandzhugazyan; Per Guldberg; Johnny Jon Fang; Rikke S Andersen; Christina Dahl; Jann Mortensen; Tim Lundby; Aase Wagner; Ian Law; Helle Broholm; Line Madsen; Christer Lundell-Ek; Morten F Gjerstorff; Henrik J Ditzel; Martin R Jensen; Walter Fischer
Journal:  Nat Commun       Date:  2018-03-06       Impact factor: 14.919

Review 9.  Cellular immunotherapy in multiple myeloma.

Authors:  Manh-Cuong Vo; Thangaraj Jaya Lakshmi; Sung-Hoon Jung; Duck Cho; Hye-Seong Park; Tan-Huy Chu; Hyun-Ju Lee; Hyeoung-Joon Kim; Sang-Ki Kim; Je-Jung Lee
Journal:  Korean J Intern Med       Date:  2019-02-15       Impact factor: 2.884

10.  Conditioning treatment with CD27 Ab enhances expansion and antitumor activity of adoptively transferred T cells in mice.

Authors:  Anna Wasiuk; Jeff Weidlick; Crystal Sisson; Jenifer Widger; Andrea Crocker; Laura Vitale; Henry C Marsh; Tibor Keler; Li-Zhen He
Journal:  Cancer Immunol Immunother       Date:  2021-05-24       Impact factor: 6.968

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.